Valuation : Medpace Holdings, Inc.

Market Cap 16.4B 14.13B 13.38B 12.13B 22.75B 1,567B 22.86B 159B 61.1B 797B 61.59B 60.24B 2,519B P/E 2026 *
33.4x
P/E 2027 * 30.7x
Enterprise Value 15.6B 13.44B 12.72B 11.53B 21.64B 1,490B 21.75B 151B 58.11B 758B 58.57B 57.29B 2,395B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 5x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day+0.75%
1 week-0.64%
Current month-1.09%
1 month-2.97%
3 months+23.67%
6 months+22.98%
Current year+4.61%
1 week 577.64
Extreme 577.64
596.98
1 month 571.01
Extreme 571.01
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%-0.64%+18.07%+110.32% 16.4B
-0.71%-6.35%-4.87%+9.03% 45.48B
+0.21%-2.98%+340.68%+519.93% 43.69B
+1.74%-2.24%+37.28%+21.57% 43.09B
+1.38%-3.28%+3.23%+65.60% 39.4B
-1.44%-5.26%+8.78%+36.85% 31.91B
+0.87%-2.60% - - 17.31B
-0.31%-2.78%+10.47%+30.49% 14.24B
+1.93%-3.55%+74.20%+39.37% 13.28B
+2.18%+2.71%-3.31%-33.72% 13.05B
Average +0.66%-2.94%+53.84%+88.83% 27.78B
Weighted average by Cap. +0.49%-3.37%+69.33%+115.69%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.33B 2.11B 3.96B 272B 3.98B 27.63B 10.63B 139B 10.71B 10.48B 438B 3.03B 2.61B 2.47B 2.24B 4.2B 289B 4.22B 29.33B 11.28B 147B 11.37B 11.12B 465B
Net income 503M 433M 410M 372M 697M 48.01B 701M 4.87B 1.87B 24.43B 1.89B 1.85B 77.18B 547M 471M 446M 404M 758M 52.22B 762M 5.3B 2.04B 26.57B 2.05B 2.01B 83.95B
Net Debt -802M -691M -655M -593M -1.11B -76.65B -1.12B -7.77B -2.99B -38.99B -3.01B -2.95B -123B -1.25B -1.08B -1.02B -926M -1.74B -120B -1.75B -12.13B -4.67B -60.86B -4.7B -4.6B -192B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
11/09/26 $587.52 +0.75% 159,087
10/09/26 $583.16 -0.54% 195,558
09/09/26 $586.30 -0.78% 206,891
08/09/26 $590.89 -0.07% 185,218
04/09/26 $591.29 -0.35% 146,430
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
587.52USD
Average target price
581.83USD
Spread / Average Target
-0.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!